Terns Pharmaceuticals, Inc. (TERN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/10/25
Terns Pharmaceuticals, Inc. - TERN-701 Investor Educational Webinar TranscriptSeeking Alpha • 09/04/25
Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025GlobeNewsWire • 08/21/25
Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatesGlobeNewsWire • 08/05/25
Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific SessionsGlobeNewsWire • 06/23/25
Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701GlobeNewsWire • 05/14/25
Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate UpdatesGlobeNewsWire • 05/08/25
Terns Pharmaceuticals to Participate in The Citizens Life Sciences ConferenceGlobeNewsWire • 04/30/25
Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a TurnaroundZacks Investment Research • 04/07/25
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)Zacks Investment Research • 04/03/25
Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)GlobeNewsWire • 04/02/25
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to BuyZacks Investment Research • 03/26/25
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate UpdatesGlobeNewsWire • 03/20/25
Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)GlobeNewsWire • 02/26/25
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare ConferenceGlobeNewsWire • 02/25/25
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceGlobeNewsWire • 02/05/25
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)GlobeNewsWire • 02/03/25
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/08/25